.Attribute Medicine, Published online: 03 September 2024 doi:10.1038/ s41591-024-03223-zThis Standpoint calls for addition of patients along with MASLD and measurement of liver results in cardio-- renal-- metabolic tests, when data propose mechanistically possible advantages and also medical safety-- and also summarizes considerations for trial concept and also governing approval.